| 注册
首页|期刊导航|中药新药与临床药理|桂枝通络片改善高脂诱导的ApoE-/-小鼠动脉粥样硬化伴骨质疏松的作用机制

桂枝通络片改善高脂诱导的ApoE-/-小鼠动脉粥样硬化伴骨质疏松的作用机制

何星灵 张诗茵 萧博迪 妮尕热·艾合买提 鲁路 倪世豪 张一慧 李思静 张小娇 李心雨 陈嘉慧 李姿儒 陈星伶 李嘉祺

中药新药与临床药理2026,Vol.37Issue(3):424-436,13.
中药新药与临床药理2026,Vol.37Issue(3):424-436,13.DOI:10.19378/j.issn.1003-9783.2026.03.005

桂枝通络片改善高脂诱导的ApoE-/-小鼠动脉粥样硬化伴骨质疏松的作用机制

Mechanistic Study on Guizhi Tongluo Tablets Ameliorating Atherosclerosis with Osteoporosis in High-Fat Diet-Fed ApoE-/-Mice

何星灵 1张诗茵 2萧博迪 2妮尕热·艾合买提 3鲁路 4倪世豪 4张一慧 5李思静 2张小娇 2李心雨 5陈嘉慧 2李姿儒 2陈星伶 2李嘉祺3

作者信息

  • 1. 福建中医药大学附属第二人民医院,福建 福州 350003||福建中医药大学第二临床医学院,福建 福州 350003||中医证候全国重点实验室,广州中医药大学第一附属医院,广东 广州 510405
  • 2. 中医证候全国重点实验室,广州中医药大学第一附属医院,广东 广州 510405||广州中医药大学第一临床医学院,广东 广州 510405||广东省中医临床研究院,广东 广州 510407||岭南医学研究中心,广东 广州 510405
  • 3. 广州中医药大学第一临床医学院,广东 广州 510405
  • 4. 中医证候全国重点实验室,广州中医药大学第一附属医院,广东 广州 510405||广东省中医临床研究院,广东 广州 510407||岭南医学研究中心,广东 广州 510405
  • 5. 广州中医药大学第一临床医学院,广东 广州 510405||广东省中医临床研究院,广东 广州 510407||岭南医学研究中心,广东 广州 510405
  • 折叠

摘要

Abstract

Objective To investigate the mechanism of action of Guizhi Tongluo Tablets(GZTL)in ameliorating atherosclerosis(AS)with osteoporosis(OP)induced by a high-fat diet in ApoE-/-mice.Methods Mass spectrometry combined with the TCMSP database was used to predict the potential targets of GZTL.GO and KEGG enrichment analyses were performed using the DAVID database,and a PPI network was constructed to screen core targets.ApoE-/-mice were randomly divided into a model group,low-and high-dose GZTL groups,and an atorvastatin calcium(ATV)group.An AS combined with OP model was established by feeding a high-fat diet for 24 weeks.C57BL/6J mice served as the control group.Serum lipid levels were detected by biochemical methods.Histopathology was observed by HE staining.Femoral microstructure was examined by micro-CT.Serum levels of bone alkaline phosphatase(BALP)and osteocalcin were measured by ELISA.Protein and mRNA expression of PI3K/AKT pathway-related molecules were detected by Western Blot and qPCR.MC3T3-E1 cells were divided into a control group(osteogenic differentiation induction),a GZTL group(osteogenic differentiation induction+GZTL-containing serum),a LY294002 group(osteogenic differentiation induction+5 μmol·L-1 LY294002),and a GZTL+LY294002 group(osteogenic differentiation induction+GZTL-containing serum+5 μmol·L-1 LY294002).Cell proliferation rate was assessed by CCK-8 assay.Mineralized nodules were observed by Alizarin red staining.mRNA expression related to the PI3K/AKT signaling pathway was detected by qPCR.Results Bioinformatics analysis identified 408 potential target genes of GZTL for treating AS with OP,suggesting mechanisms involving lipid metabolism and the PI3K-AKT signaling pathway.In vivo experiments showed that compared with the model group,mice in the GZTL dose groups and the ATV group exhibited decreased serum lipid levels(P<0.05,P<0.01),improved lipid deposition and hepatic steatosis,significantly improved femoral microstructure(P<0.05,P<0.01),significantly increased serum BALP and osteocalcin levels(P<0.05,P<0.01),and significantly upregulated ratios of p-PI3K/PI3K,p-AKT/AKT,and mRNA expression of Pi3k and Akt in bone tissue(P<0.05,P<0.01).In vitro experiments showed that GZTL-containing serum promoted the proliferation and osteogenic differentiation of MC3T3-E1 cells,enhanced the formation of mineralized nodules,and significantly upregulated Pi3k and Akt mRNA levels(P<0.01).These effects were partially antagonized by the PI3K inhibitor.Conclusion GZTL exerts a dual effect in the prevention and treatment of AS with OP by regulating lipid metabolism and promoting osteogenic differentiation.Its mechanism is closely related to the regulation of the PI3K/AKT signaling pathway.

关键词

桂枝通络片/动脉粥样硬化/骨质疏松/质谱分析/网络药理学/脂质代谢/PI3K/AKT通路/MC3T3-E1/ApoE-/-小鼠

Key words

Guizhi Tongluo Tablets/atherosclerosis/osteoporosis/mass spectrometry/network pharmacology/lipid metabolism/PI3K/AKT pathway/MC3T3-E1/ApoE-/-mice

分类

医药卫生

引用本文复制引用

何星灵,张诗茵,萧博迪,妮尕热·艾合买提,鲁路,倪世豪,张一慧,李思静,张小娇,李心雨,陈嘉慧,李姿儒,陈星伶,李嘉祺..桂枝通络片改善高脂诱导的ApoE-/-小鼠动脉粥样硬化伴骨质疏松的作用机制[J].中药新药与临床药理,2026,37(3):424-436,13.

基金项目

国家自然科学基金项目(82505436,82374406) (82505436,82374406)

广东省医学科学技术研究基金项目(B2025119) (B2025119)

广州市2025年"青年科技人才托举工程"项目(QT-2025-037) (QT-2025-037)

广州中医药大学"固本"工程一级学科能力提升项目(GZY2025GB0104) (GZY2025GB0104)

广州中医药大学第一临床医学院2025年院级"揭榜挂帅"研究生创新能力提升项目(A3-0317-25-110-002) (A3-0317-25-110-002)

2025年度大学生创新创业训练计划项目(202510572025). (202510572025)

中药新药与临床药理

1003-9783

访问量0
|
下载量0
段落导航相关论文